rise by assuta-logo



The center of
excellence for pathology innovation

DATA AND BIO-SAMPLES CATALOG

In the catalog below, you will be able to learn more about the data and samples we can provide access to, including the availability of additional information.

FIELDS OF ACTIVITY - RISE

DIAGNOSED SCANNED HISTOPATHOLOGY CASES

ORGANS
GI & Bile
N. of patients
56,654
Available procedures
61%
Malignant diagnoses
2%
Imaging modalities
78%
ORGANS
Skin
N. of patients
43,905
Available procedures
27%
Malignant diagnoses
6%
Imaging modalities
80%
ORGANS
Gynecology
N. of patients
20,896
Available procedures
37%
Malignant diagnoses
4%
Available imaging
82%
ORGANS
Breast
N. of patients
14,530
Available procedures
52%
Malignant diagnoses
35%
Available imaging
95%
ORGANS
Urology
N. of patients
2,776
Available procedures
73%
Malignant diagnoses
36%
Available imaging
80%
ORGANS
Others
N. of patients
132,037
Available procedures
30%
Malignant diagnoses
1%
Available imaging
82%
ORGANS N. of patients Available procedures Malignant diagnoses Available imaging
GI & Bile 56,654 61% 2% 78%
Skin 43,905 27% 6% 80%
Gynecology 20,896 37% 4% 82%
Breast 14,530 52% 35% 95%
Urology 2,776 73% 36% 80%
Others 132,037 30% 1% 82%

CASES WITH COMPLETE BACKGROUND
AND OUTCOME

Organ
Gastro
N. of patients
27,572
Available MRI
2.4%
Available US
38.5%
Available PET-CT
0.1%
Oncology treatment available
0.6%
Malignant diagnoses
0.5%
IBD DIAGNOSIS
4.5%
Organ
Skin
N. of patients
22,050
Available MRI
0.0%
Available US
0.0%
Available PET-CT
0.0%
Oncology treatment available
0.4%
Malignant diagnoses
32.1%
IBD DIAGNOSIS
1.0%
Organ
Breast
N. of patients
5,103
Available MRI
7.7%
Available US
56.1%
Available PET-CT
0.0%
Oncology treatment available
2.1%
Malignant diagnoses
30.6%
IBD DIAGNOSIS
0.7%
Organ
Prostate
N. of patients
860
Available MRI
39.4%
Available US
75.1%
Available PET-CT
0.0%
Oncology treatment available
0.5%
Malignant diagnoses
38.3%
IBD DIAGNOSIS
0.6%
Organ
Gallbladder
N. of patients
767
Available MRI
5.7%
Available US
79.5%
Available PET-CT
0.0%
Oncology treatment available
0.5%
Malignant diagnoses
0.0%
IBD DIAGNOSIS
1.2%
Organ
Colon
N. of patients
736
Available MRI
0.0%
Available US
24.9%
Available PET-CT
0.0%
Oncology treatment available
0.7%
Malignant diagnoses
5.7%
IBD DIAGNOSIS
3.4%
Organ
Bladder
N. of patients
214
Available MRI
0.0%
Available US
70.6%
Available PET-CT
0.5%
Oncology treatment available
1.4%
Malignant diagnoses
89.7%
IBD DIAGNOSIS
1.9%
Organ
Thyroid
N. of patients
122
Available MRI
0.0%
Available US
73.0%
Available PET-CT
28.7%
Oncology treatment available
1.6%
Malignant diagnoses
34.4%
IBD DIAGNOSIS
0.0%
Organ
Lymph nodes
N. of patients
115
Available MRI
0.0%
Available US
0.0%
Available PET-CT
27.8%
Oncology treatment available
11.3%
Malignant diagnoses
5.2%
IBD DIAGNOSIS
0.0%
Organ N. of patients Available MRI Available US Available PET-CT Oncology treatment available Malignant diagnoses IBD DIAGNOSIS
Gastro 27,572 2.4% 38.5% 0.1% 0.6% 0.5% 4.5%
Skin 22,050 0.0% 0.0% 0.0% 0.4% 32.1% 1.0%
Breast 5,103 7.7% 56.1% 0.0% 2.1% 30.6% 0.7%
Prostate 860 39.4% 75.1% 0.0% 0.5% 38.3% 0.6%
Gallbladder 767 5.7% 79.5% 0.0% 0.5% 0.0% 1.2%
Colon 736 0.0% 24.9% 0.0% 0.7% 5.7% 3.4%
Bladder 214 0.0% 70.6% 0.5% 1.4% 89.7% 1.9%
Thyroid 122 0.0% 73.0% 28.7% 1.6% 34.4% 0.0%
Lymph nodes 115 0.0% 0.0% 27.8% 11.3% 5.2% 0.0%

patho-lab
Diagnostics

Following decades of experience and expertise in the provision of pathology diagnostic services, Patho-Lab Diagnostics became a part of Assuta Medical Centers in 2019.
Patho-Lab’s clinical experts operate in a cutting-edge facility, performing extensive analyses of over 236,200 biopsies and processing over 339,600 paraffin blocks each year.

The lab established a collaboration with Assuta and Leumit Healthcare Services – the Center of Excellence for Pathology Innovation.
This new endeavour aims to significantly increase the availability of vital pathology data and samples, aiding the progression of research and the development of innovative healthcare solutions.